Chapter 3 — One Prediction for the Lab
Elias did not ask Juno to trust him. He asked her to prove one fact.
She predicted that a lab ferret exposed to the sealed pathogen would develop a black capillary bloom behind the eyes exactly fourteen hours after fever. Kane Biotech could verify the sign without infecting anything new because archived trial footage existed.
Elias requested the footage through scientific compliance. The board initially denied that the trial occurred. Juno supplied the old project code.
At fourteen hours, the ferret's recorded eyes darkened.
Elias negotiated a supervised access agreement. Juno could examine deidentified sequence data and observe nonliving samples through containment glass. She could not remove material, direct experiments, or copy proprietary research. In return, she disclosed three additional predictions to an independent public-health escrow, released when verified.
“Why an escrow?” Elias asked.
“So neither of us can bury the warnings if our relationship changes.”
He accepted.
The Kane laboratory showed why the cure failed in the first timeline. Researchers had found an antiviral vector that reduced neurological aggression but abandoned it after infected tissue mutated around one protein. The board cut funding because the market for an unrecognized disease did not exist.
Juno identified a second protein target remembered from later experiments. She did not claim scientific authorship. She asked researchers to test the combination under their own protocol.
Elias watched her move through data with unsettling accuracy. “You know outcomes, not methods.”
“Correct.”
“Which means either someone showed you future research or—”
“Do not finish a theory you cannot test.”
He smiled despite himself. “You negotiate like a scientist.”
“I negotiate like someone who has been treated as material.”
The words escaped before she intended. Elias did not press.
Juno traded her outbreak-location prediction for access to procurement records. Kane Biotech had ordered unusual nerve suppressants through a subsidiary tied to Sora's startup. The compounds matched drugs used on Juno in the bunker.
Sora worked as a public-health influencer and nominal founder. She lacked laboratory credentials. Yet her access badge entered the sealed freezer twice in one month.
Elias requested security footage. His board mentor, Dr. Victor Hale, advised against “family accusations based on badge anomalies.” Elias preserved the footage before notifying the board.
It showed Sora in protective gear removing three vials and replacing them with saline.
Juno watched her sister steal the pathogen that would end the world.
In the first timeline, officials claimed the outbreak began through an animal-market mutation. Juno had never known Sora carried samples before collapse.
“Call public health,” Elias said.
“Preserve chain first. If your board controls the report, they will bury it.”
They notified an independent biosafety regulator, transferred footage checksums, and locked remaining samples under dual control. Sora's stolen vials had disappeared from inventory six weeks earlier.
Mei called during the search. “Why are you harassing your sister's company?”
Juno put the call on record after informing her. “Did you know Sora accessed Kane's freezer?”
“She was protecting her investors.”
Not denial.
Mei demanded Juno end the complaint or face a public capacity petition. Juno sent the recording to her lawyer.
The regulator searched Sora's startup. Freezers were empty, but invoices showed animal testing at a private clinic. Staff reported one technician hospitalized with unexplained fever.
Juno checked the date.
The first timeline's outbreak had begun three weeks later. Their intervention might have accelerated exposure—or revealed what was already happening.
Elias's board suspended him for reporting without authorization. He retained a minority share and scientific license but lost laboratory access.
Juno still had one route inside. Kane's emergency bylaws granted temporary board authority to spouses of incapacitated controlling heirs during a public-health threat. The rule existed to keep family control, but it could open the buried research.
Elias looked at her. “You are not suggesting romance.”
“No. I am suggesting a legal instrument with an exit date.”
Before they could negotiate, the regulator sent the clinic's security footage.
The room went silent except for ventilation. Elias replayed the ferret sequence frame by frame, then asked the archivist to prove the file had not been altered. Its checksum matched a tape sealed two years earlier. Juno had never entered the building before that morning.
“One accurate detail could be stolen,” compliance counsel said. “A project code and an unrecorded symptom make theft harder to explain.”
“Do not explain her,” Elias replied. “Test her claims.”
Juno noticed the distinction. In her first life, men with titles wasted weeks deciding whether she was credible while bodies accumulated. Elias moved the question from her character to measurable evidence.
The project's financial history was worse than scientific failure. Kane had claimed a tax credit for antiviral research, then reassigned the useful equipment to a cosmetic-aging division. Public money absorbed the risk while shareholders retained the patents. Elias authorized the regulator to see that ledger too.
“You are exposing your own company,” Juno said.
“It is not mine when it can bury evidence I am required to report.”
“You still own shares.”
“Then I may lose money. That is less serious than losing a city.”
Sacrifice was easy to promise when it remained romantic and distant. Elias had put a number on his, signed beneath it, and sent the evidence to people capable of enforcing the loss.
The procurement records made Juno's fingers go cold. She remembered the suppressants as a metallic taste, a bright lamp, and Sora asking technicians to raise the dose because Juno kept moving objects into the vault before they could inventory them. The memory was not evidence in this life. She forced her breathing to slow and copied only admissible invoice numbers.
Elias placed water within reach without touching her. “Do you need the room cleared?”
“No. Five minutes.”
He ordered a break and gave no explanation. When they returned, Juno had built a timeline from orders, badge logs, and delivery confirmations. Her fear had become a chain of custody.
A four-minute power interruption coincided with Sora's second freezer entry. Someone with facilities access disabled the internal camera but missed a reflection in the corridor lens. Victor's credentials had opened the maintenance panel twenty minutes earlier. It did not prove conspiracy, but it destroyed his claim that Sora acted without help.
Elias sealed a copy with regulators. Juno did the same, surrendering control because evidence mattered only if other people could trust how it survived.
Sora had personally injected the hospitalized technician with a stolen vial.